✦ LIBER ✦

Update on Clinical Data with Regimens Inhibiting Angiogenesis and Epidermal Growth Factor Receptor for Patients with Newly Diagnosed Metastatic Colorectal Cancer

✍ Scribed by Deirdre J. Cohen; Howard S. Hochster

Book ID: 119935177
Publisher: CIG Media Group, LP.
Year: 2007
Tongue: English
Weight: 113 KB
Volume: 7
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2008.s.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Retrospective on the Inhibition of Epi

A Retrospective on the Inhibition of Epidermal Growth Factor Receptor as a Therapeutic Strategy for Patients with Relapsed Metastatic Colorectal Cancer: Impact on Treatment of Today's Patients

✍ Christopher Jackson; David Cunningham 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 128 KB

First clinical experience of orally acti

First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer

✍ Maria Giulia Zampino; Elena Magni; Cristian Massacesi; Alberto Zaniboni; Angelo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

## Abstract ## BACKGROUND. Gefitinib, an orally active inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, combined with chemotherapy, has shown efficacy as second‐line treatment for advanced colorectal cancer (CRC). Gefitinib combined with FOLFOX6 (oxaliplatin plus folinic acid

3019 POSTER Association of gene copy num

3019 POSTER Association of gene copy number (GCN) of the epidermal growth factor receptor (EGFr) and clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with panitumumab monotherapy

✍ J. Berlin; J.R. Hecht; M. Reiner; M. Mullenix; S. Suggs; R. Radinsky; D. Freeman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Promising biomarkers for predicting the

Promising biomarkers for predicting the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis

✍ Yang, Zu-Yao; Wu, Xin-Yin; Huang, Ya-Fang; Di, Meng-Yang; Zheng, Da-Yong; Chen, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 French ⚖ 937 KB

Recommendations on Disease Management fo

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline

✍ Ramakrishna, N.; Temin, S.; Chandarlapaty, S.; Crews, J. R.; Davidson, N. E.; Es 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 114 KB

Predictive value of epidermal growth fac

Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studies

✍ Licitra, Lisa; Störkel, Stephan; Kerr, Keith M.; Van Cutsem, Eric; Pirker, Rober 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 370 KB